Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Neumayer

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipientsP Glander, P Hambach, K P Braun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantationB Fellström, A G Jardine, I Soveri, et al.
Transplantation|August 1, 1991
Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipientsU Kunzendorf, G Walz, J Brockmoeller, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pathophysiology in endothelin-1 transgenic miceF Theuring, C Thöne-Reinecke, H Vogler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patientsK Budde, S Bauer, P Hambach, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysisS Morgera, H H Neumayer, L Fritsche, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Cyclosporin C2hour monitoring after renal transplantationG Einecke, I Mai, L Fritsche, et al.
Klinische Wochenschrift|November 15, 1983
Elimination kinetics of plasma exchangeF Keller, K Wagner, U Faber, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2001
Pharmacodynamic monitoring of mycophenolate mofetilK Budde, P Glander, S Bauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 1, 1990
[Calcinosis cutis: cutaneous manifestations of generalized calcinosis in renal hyperparathyroidism]C C Zouboulis, J Weihe, H Gollnick, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipientsP Glander, P Hambach, K P Braun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantationB Fellström, A G Jardine, I Soveri, et al.
Transplantation|August 1, 1991
Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipientsU Kunzendorf, G Walz, J Brockmoeller, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pathophysiology in endothelin-1 transgenic miceF Theuring, C Thöne-Reinecke, H Vogler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patientsK Budde, S Bauer, P Hambach, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysisS Morgera, H H Neumayer, L Fritsche, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Cyclosporin C2hour monitoring after renal transplantationG Einecke, I Mai, L Fritsche, et al.
Klinische Wochenschrift|November 15, 1983
Elimination kinetics of plasma exchangeF Keller, K Wagner, U Faber, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2001
Pharmacodynamic monitoring of mycophenolate mofetilK Budde, P Glander, S Bauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 1, 1990
[Calcinosis cutis: cutaneous manifestations of generalized calcinosis in renal hyperparathyroidism]C C Zouboulis, J Weihe, H Gollnick, et al.
Pageof 15